Publications found:
1,182
Sort by:
Precision Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End User (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Healthcare Data Companies) Region and Competition, 2020-2030F
US$ 4,500.00
The Global Precision Oncology Market , valued at USD 99.45 Billion in 2024, is projected to experience a CAGR of 9.12% to reach USD 167.87 Billion by 2030. Precision oncology tailors cancer treatment...
December 2025
183 pages
Acute Myeloid Leukemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, hormonal therapy, and other chemotherapies), By Region, and Competition, 2020-2030F
US$ 4,500.00
The Global Acute Myeloid Leukemia Market, valued at USD 1.56 Billion in 2024, is projected to experience a CAGR of 8.90% to reach USD 2.63 Billion by 2030. Acute Myeloid Leukemia (AML) is a rapidly pr...
December 2025
183 pages
Breast Cancer Drugs Market Size, Share & Trends Analysis Report By Therapy (Hormonal Therapy, Targeted Therapy, Chemotherapy, Immunotherapy), By Cancer Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global breast cancer drugs market size was estimated at USD 36.62 billion in 2024 and is projected to reach USD 69.72 billion by 2033, growing at a CAGR of 7.09% from 2025 to 2033. The market is...
December 2025
150 pages
Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (B-cell Lymphomas, T-cell Lymphoma), By Drug Class (Monoclonal Antibodies, Antibody-Drug Conjugates, BTK/BCL-2 Kinase Inhibitors, PI3 Kinase Inhibitors, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Non-Hodgkin Lymphoma Market, valued at USD 7.24 Billion in 2024, is projected to experience a CAGR of 7.72% to reach USD 11.31 Billion by 2030. The global Non-Hodgkin Lymphoma market compri...
November 2025
187 pages
Global Hepatocellular Carcinoma Market - 2022-2031
US$ 2,999.00
The Global Hepatocellular Carcinoma Market was valued at USD 977 million in 2022 and is anticipated to reach USD 2.4 billion by 2031, at a CAGR of 0.122 from 2026 to 2032. The report delivers in-depth...
November 2025
243 pages
Acute Lymphocytic Leukemia Therapeutics Market - 2022-2031
US$ 2,999.00
The Acute Lymphocytic Leukemia Therapeutics Market was valued at US$ 2.9 billion in 2022 and is anticipated to reach US$ 4.5 billion by 2031, at a CAGR of 0.058 from 2026 to 2032. The report delivers...
November 2025
223 pages
Adenoid Cystic Carcinoma Market - 2022-2030
US$ 2,999.00
The Adenoid Cystic Carcinoma Market was valued at US$ 224.3 million in 2022 and is anticipated to reach US$ 344.6 million by 2030, at a CAGR of 0.056 from 2026 to 2032. The report delivers in-depth in...
November 2025
200 pages
Alveolar Rhabdomyosarcoma Treatment Market 2026
US$ 2,999.00
The Alveolar Rhabdomyosarcoma Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inc...
November 2025
220 pages
Anal Cancer Market 2026
US$ 2,999.00
The Anal Cancer Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth t...
November 2025
219 pages
Angioimmunoblastic T-Cell Lymphoma Market 2026
US$ 2,999.00
The Angioimmunoblastic T-Cell Lymphoma Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...
November 2025
219 pages
Appendix Cancer Drugs Market 2026
US$ 2,999.00
The Appendix Cancer Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
November 2025
207 pages
Asia Pacific Leukemia Therapeutics Market - 2023-2031
US$ 2,999.00
The Asia Pacific Leukemia Therapeutics Market was valued at US$ 340 million in 2023 and is anticipated to reach US$ 567.18 million by 2031, at a CAGR of 0.067 from 2026 to 2032. The report delivers in...
November 2025
220 pages
Bile Duct Cancer Market 2026
US$ 2,999.00
The Bile Duct Cancer Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gro...
November 2025
243 pages
Bile Duct Cancer Treatment Market 2026
US$ 2,999.00
The Bile Duct Cancer Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.085 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
November 2025
217 pages
Bone Cancer Market 2026
US$ 2,999.00
The Bone Cancer Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth t...
November 2025
223 pages
Cancer Angiogenesis Inhibitors Market 2026
US$ 2,999.00
The Cancer Angiogenesis Inhibitors Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
223 pages
Cancer Anorexia-Cachexia Syndrome Drug Market 2026
US$ 2,999.00
The Cancer Anorexia-Cachexia Syndrome Drug Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
November 2025
223 pages
Cancer Cachexia Market 2026
US$ 2,999.00
The Cancer Cachexia Market was valued at in and is anticipated to reach by , at a CAGR of 0.068 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...
November 2025
223 pages
Cancer CDK Inhibitors Market - 2023-2031
US$ 2,999.00
The Cancer CDK Inhibitors Market was valued at US$ 9.3 billion in 2023 and is anticipated to reach US$ 13.8 billion by 2031, at a CAGR of 0.052 from 2026 to 2032. The report delivers in-depth insights...
November 2025
200 pages
Cancer Treatment Drugs Market - 2021
US$ 2,999.00
The Cancer Treatment Drugs Market was valued at USD 153.23 million in 2021 and is anticipated to reach by , at a CAGR of 0.106 from 2026 to 2032. The report delivers in-depth insights into key market...
November 2025
219 pages
Capecitabine Market 2026
US$ 2,999.00
The Capecitabine Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth...
November 2025
218 pages
Castrate Resistant Prostate Cancer Therapeutics Market 2026
US$ 2,999.00
The Castrate Resistant Prostate Cancer Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.084 from 2026 to 2032. The report delivers in-depth insights into key market...
November 2025
223 pages
Castration Resistant Prostate Cancer Treatment Market 2026
US$ 2,999.00
The Castration Resistant Prostate Cancer Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.09 from 2026 to 2032. The report delivers in-depth insights into key market d...
November 2025
217 pages
CD Antigen Cancer Therapy Market 2026
US$ 2,999.00
The CD Antigen Cancer Therapy Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
November 2025
218 pages
Chemotherapy Induced Anemia Market - 2022
US$ 2,999.00
The Chemotherapy Induced Anemia Market was valued at USD 2,240 million in 2022 and is anticipated to reach by , at a CAGR of 0.072 from 2026 to 2032. The report delivers in-depth insights into key mar...
November 2025
207 pages
Chemotherapy-Induced Thrombocytopenia Market 2026
US$ 2,999.00
The Chemotherapy-Induced Thrombocytopenia Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, i...
November 2025
243 pages
Chondrosarcoma Market 2026
US$ 2,999.00
The Chondrosarcoma Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growt...
November 2025
243 pages
Chronic Myelogenous Leukemia Treatment Market 2026
US$ 2,999.00
The Chronic Myelogenous Leukemia Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
November 2025
210 pages
DDR Defective Tumors Market 2026
US$ 2,999.00
The DDR Defective Tumors Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
223 pages
Differentiated Thyroid Cancer Drugs Market 2026
US$ 2,999.00
The Differentiated Thyroid Cancer Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inc...
November 2025
219 pages
Europe Cancer Cachexia Market - 2022-2030
US$ 2,999.00
The Europe Cancer Cachexia Market was valued at US$ 618.75 million in 2022 and is anticipated to reach US$ 897.58 million by 2030, at a CAGR of 0.048 from 2026 to 2032. The report delivers in-depth in...
November 2025
210 pages
Europe Leukemia Therapeutics Market - 2023-2031
US$ 2,999.00
The Europe Leukemia Therapeutics Market was valued at US$ 4.7 billion in 2023 and is anticipated to reach US$ 7.56 billion by 2031, at a CAGR of 0.063 from 2026 to 2032. The report delivers in-depth i...
November 2025
217 pages
Europe Liver Cancer Therapeutics Market - 2022-2030
US$ 2,999.00
The Europe Liver Cancer Therapeutics Market was valued at US$ 384 million in 2022 and is anticipated to reach US$ 627 million by 2030, at a CAGR of 0.0895 from 2026 to 2032. The report delivers in-dep...
November 2025
220 pages
Eye Cancer Treatment Market 2026
US$ 2,999.00
The Eye Cancer Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.07 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
November 2025
218 pages
Gemcitabine HCL Market 2026
US$ 2,999.00
The Gemcitabine HCL Market was valued at in and is anticipated to reach by , at a CAGR of 0.07 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gro...
November 2025
243 pages
Gestational Trophoblastic Disease Market 2026
US$ 2,999.00
The Gestational Trophoblastic Disease Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inclu...
November 2025
218 pages
Hairy Cell Leukemia Market 2026
US$ 2,999.00
The Hairy Cell Leukemia Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
219 pages
Hepatoblastoma Market - 2022-2031
US$ 2,999.00
The Hepatoblastoma Market was valued at USD 366.7 million in 2022 and is anticipated to reach USD 688.2 million by 2031, at a CAGR of 0.084 from 2026 to 2032. The report delivers in-depth insights int...
November 2025
243 pages
Hodgkin’s Lymphoma Market - 2022
US$ 2,999.00
The Hodgkin’s Lymphoma Market was valued at US$ 0.9 billion in 2022 and is anticipated to reach by , at a CAGR of 0.098 from 2026 to 2032. The report delivers in-depth insights into key market dynamic...
November 2025
243 pages
Hormone Refractory Prostate Cancer (HRPCA) Market 2026
US$ 2,999.00
The Hormone Refractory Prostate Cancer (HRPCA) Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynami...
November 2025
210 pages
Insulinoma Treatment Market 2026
US$ 2,999.00
The Insulinoma Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
220 pages
Isocitrate Dehydrogenase Inhibitors Market 2026
US$ 2,999.00
The Isocitrate Dehydrogenase Inhibitors Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inc...
November 2025
210 pages
Kaposi Sarcoma Market 2026
US$ 2,999.00
The Kaposi Sarcoma Market was valued at in and is anticipated to reach by , at a CAGR of 0.055 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gro...
November 2025
219 pages
Langerhans Cell Histiocytosis Management Market - 2023-2031
US$ 2,999.00
The Langerhans Cell Histiocytosis Management Market was valued at US$ 865.4 million in 2023 and is anticipated to reach US$ 1409.4 million by 2031, at a CAGR of 0.064 from 2026 to 2032. The report del...
November 2025
243 pages
Leukapheresis Market 2026
US$ 2,999.00
The Leukapheresis Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth...
November 2025
218 pages
Malignant Mesothelioma Therapeutics Market - 2022
US$ 2,999.00
The Malignant Mesothelioma Therapeutics Market was valued at USD 259.3 million in 2022 and is anticipated to reach by , at a CAGR of 0.091 from 2026 to 2032. The report delivers in-depth insights into...
November 2025
218 pages
Malignant Pleural Mesothelioma Treatment Market - 2023-2031
US$ 2,999.00
The Malignant Pleural Mesothelioma Treatment Market was valued at US$ 387.73 million in 2023 and is anticipated to reach US$ 649.83 million by 2031, at a CAGR of 0.068 from 2026 to 2032. The report de...
November 2025
207 pages
Merkel Cell Carcinoma Market 2026
US$ 2,999.00
The Merkel Cell Carcinoma Market was valued at in and is anticipated to reach by , at a CAGR of 0.087 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
November 2025
210 pages
